by agenda | Apr 19, 2022 | News
Supply chain disruption will be with biopharmaceutical companies for the foreseeable future, according to the recent CFO survey, Supply Chain Resilience, by BDO. A separate report by Catalent, Allogeneic and Autologous Cell Therapies Report 2022, agrees, saying,...
by agenda | Dec 20, 2021 | News
Tony Quinones, CEO of Bright Path Laboratories, discusses the latest on the omicron variant and Covid vaccines with Bryan Curtis and Paul Allen on Bloomberg Daybreak Asia....
by agenda | Dec 20, 2021 | News
Bright Path CEO Tony Quinone joins Yahoo Finance to discuss how the Build Back Better Plan will promote locally produced pharmaceutical...
by agenda | Jan 28, 2021 | News
Vice-Chairman of the Coalition for a Prosperous America. Bright Path Labs has appointed Mr. Marc Fasteau as an independent director. Tony Quinones, CEO of BPL, stated, “We are extraordinarily honored and pleased that Mr. Fasteau has elected to join our board as...
by agenda | Dec 12, 2020 | News
Bright Path Labs has a technology that brings speed to the commercialization of API production. Continuous manufacturing is a big need in the pharmaceutical sector and Bright Path lab’s technology accelerates that process. In order to enable and commercialize...
